Accelerate Diagnostics (MEX:AXDX) OCF Margin %: -179.97% (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AXDX Accelerate Diagnostics Inc MEX:AXDX
12 GF Score
Price MXN1.75
View Full Analysis

What is Accelerate Diagnostics OCF Margin %?

Accelerate Diagnostics MEX:AXDX 12 OCF Margin % is -179.97% as of Dec. 2024. GuruFocus rates MEX:AXDX with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Accelerate Diagnostics's Cash Flow from Operations for the three months ended in Dec. 2024 was MXN-105.7 Mil. Accelerate Diagnostics's Revenue for the three months ended in Dec. 2024 was MXN58.7 Mil. Therefore, Accelerate Diagnostics's OCF Margin % for the quarter that ended in Dec. 2024 was -179.97%.

As of today, Accelerate Diagnostics's current OCF Yield % is -309,763.64%.

The historical rank and industry rank for Accelerate Diagnostics's OCF Margin % or its related term are showing as below:

MEX:AXDX' s OCF Margin % Range Over the Past 10 Years
Min: -23897.45   Med: -574.15   Max: -206.82
Current: -202.57

During the past 13 years, the highest OCF Margin % of Accelerate Diagnostics was -206.82%. The lowest was -23897.45%. And the median was -574.15%.

MEX:AXDX's OCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 6.645 vs MEX:AXDX: -202.57

Accelerate Diagnostics OCF Margin % Related Terms

Accelerate Diagnostics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Accelerate Diagnostics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerate Diagnostics OCF Margin % Chart

Accelerate Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -451.36 -401.65 -382.12 -333.33 -206.82

Accelerate Diagnostics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -256.19 -289.35 -253.95 -103.90 -179.97

MEX:AXDX vs MSIU, BIOLQ, AFIB: OCF Margin % Comparison

For the Medical Devices subindustry, Accelerate Diagnostics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerate Diagnostics OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Accelerate Diagnostics's OCF Margin % falls into.


MEX:AXDX
12GF Score
Accelerate Diagnostics Inc MEX:AXDX
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accelerate Diagnostics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Accelerate Diagnostics's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-504.583/243.97
=-206.82 %

Accelerate Diagnostics's OCF Margin for the quarter that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-105.697/58.73
=-179.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -179.97% mean?
Accelerate Diagnostics (MEX:AXDX) has a OCF Margin % of -179.97% as of Dec. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Accelerate Diagnostics and its competitors.
Is Accelerate Diagnostics' OCF Margin % too high?
Accelerate Diagnostics' current OCF Margin % is -179.97%. Overall, Accelerate Diagnostics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Accelerate Diagnostics' OCF Margin % compare to MSIU and BIOLQ?
Accelerate Diagnostics' OCF Margin % of -179.97% can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Margin % is 6.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.65, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Accelerate Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accelerate Diagnostics's current OCF Margin % is -179.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accelerate Diagnostics stock overvalued right now?
Accelerate Diagnostics (MEX:AXDX) has a current OCF Margin % of -179.97%. The current OCF Margin % is -179.97%. Accelerate Diagnostics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Accelerate Diagnostics (MEX:AXDX), the current OCF Margin % is -179.97% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accelerate Diagnostics Business Description

Address 3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
12GF Score

Get the complete analysis for MEX:AXDX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1.75
Price